Applied Concepts in PBPK Modeling: How to Extend an Open Systems Pharmacology Model to the Special Population of Pregnant Women by André Dallmann, Juri Solodenko, Ibrahim Ince, Thomas Eissing

Connect to this object online.

A Physiologically‐Based Quantitative Systems Pharmacology Model of the Incretin Hormones GLP‐1 and GIP and the DPP4 Inhibitor Sitagliptin by Pavel Balazki, Stephan Schaller, Thomas Eissing, Thorsten Lehr

Connect to this object online.

Physiologically‐based pharmacokinetic modeling to predict CYP3A4‐mediated drug‐drug interactions of finerenone by Thomas Wendl, Sebastian Frechen, Michael Gerisch, Roland Heinig, Thomas Eissing

Connect to this object online.

Physiologically Based Pharmacokinetic Modeling of Monoclonal Antibodies in Pediatric Populations Using PK-Sim by Sumit Basu, Yi Ting (Kayla), Valvanera Vozmediano, Jan-Frederik Schlender, Thomas Eissing, Stephan Schmidt, Christoph Niederalt

Connect to this object online.

Application of Physiologically‐Based and Population Pharmacokinetic Modeling for Dose Finding and Confirmation During the Pediatric Development of Moxifloxacin by Stefan Willmann, Matthias Frei, Gabriele Sutter, Katrin Coboeken, Thomas Wendl, Thomas Eissing, Jörg Lippert, Heino Stass

Connect to this object online.

Physiologically‐Based Pharmacokinetic Models for CYP1A2 Drug-Drug Interaction Prediction: A Modeling Network of Fluvoxamine, Theophylline, Caffeine, Rifampicin, and Midazolam by Hannah Britz, Nina Hanke, Anke‐Katrin Volz, Olav Spigset, Matthias Schwab, Thomas Eissing, Thomas Wendl, Sebastian Frechen, Thorsten Lehr

Connect to this object online.